Jeff Galvin Is Taking a New Approach to Medicine There’s a revolution brewing in medicine, and the paradigm-shifting innovations in the gene and cell therapy space are right at the heart of the movement. Jeff Galvin, CEO of American Gene Technologies® (AGT ™) and Addimmune™, has seen firsthand what gene and cell therapies can do. With a background in economics, software and engineering he has a remarkable vision of how these technologies will change the healthcare landscape. Genetic medicine...